- €558.03m
- €361.51m
- €6.05bn
- 74
- 93
- 75
- 95
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,880 | 4,652 | 5,170 | 5,786 | 6,049 |
Cost of Revenue | |||||
Gross Profit | 1,598 | 1,538 | 1,726 | 1,811 | 1,912 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4,826 | 4,689 | 5,075 | 5,666 | 5,908 |
Operating Profit | 54.7 | -37.2 | 95.2 | 120 | 140 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 37.4 | -51 | 85.4 | 110 | 131 |
Provision for Income Taxes | |||||
Net Income After Taxes | 27.8 | -42.4 | 61.4 | 82.6 | 95 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 25.5 | -47.6 | 53.7 | 78.6 | 99.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 14.3 | -65.8 | 35.9 | 64.4 | 85 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.015 | -2.82 | 0.919 | 1.2 | 1.59 |
Dividends per Share |